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Abstract
Background: In managing hip fracture, effective pain relief before admission to hospital is difficult without risking
side effects. Although emergency departments routinely use fascia iliaca compartment block (FICB), there has been
little evaluation of its use by paramedics before hospital admission. We aimed to assess whether a multi-centre
randomised trial to evaluate FICB was feasible.
Methods: Volunteer paramedics used scratchcards to allocate patients with hip fracture at random between FICB
and pain relief as usual. Primary outcomes were mortality and quality of life. We also measured adverse events,
costs, final diagnosis, length of stay in hospital, pain scores and quality of care and collected qualitative data about
acceptability to patients in interviews, and paramedics in focus groups. We pre-specified criteria for deciding
whether to progress to a fully powered trial based on the recruitment of paramedics and patients, delivery of FICB,
retrieval of outcome data, safety, acceptability, and diagnostic accuracy of hip fracture.
Results: We effectively met all progression criteria: we recruited 19 paramedics who randomly allocated 71 patients
between trial arms between 28 June 2016 and 31 July 2017; 57 (31 experimental arm, 26 usual care arm, 80%
overall) retrospectively consented to follow-up. Just over half (17/31) of experimental participants received FICB; all
others had contraindications, including nine taking anticoagulants. Four of the 31 participants assigned FICB and six
of the 26 assigned usual care died within 6 months of hospital admission. Serious adverse events were also similar:
3/35 experimental versus 4/36 in usual care. Paramedics’ recognition of hip fracture had sensitivity of 49/64 (77%)
with a positive predictive value of 46/57 (81%). We received quality of life questionnaires for 30 of 49 patients (61%)
at 1month and 12 of 17 (71%) at 6 months. Patient satisfaction was similar: experimental mean 3.4 (n = 20) versus 3.5
(n = 13) for usual care.
Conclusions: RAPID met all progression criteria within reasonable limits. As equipoise remains, we plan to undertake a
fully powered multi-centre trial to test clinical and cost effectiveness of paramedic-administered FICB at the scene of
hip fracture.
Trial registration: ISRCTN 60065373 sought 5 November 2015.
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Introduction
Background
Hip fracture is a common, very painful injury, particu-
larly affecting vulnerable elderly people [1]. Hip fractures
generate more admissions to orthopaedic trauma wards
than any other injury, and an average inpatient stay of
21 days, thus accounting for 2.5% of all hospital beds [2].
This has a major financial effect on the National Health
Service (NHS) [3]. Hip fracture is followed by high
short-term mortality − 5% at 30 days, 10% at 6 months,
and 20% at 1 year [4–6], and delay to surgery beyond 48
h makes outcomes worse [7–9].
Prehospital management of patients with hip fracture
can exacerbate pain as the injury site is difficult to im-
mobilise. Paramedics can administer paracetamol, opi-
oids, and Entonox; intravenous (IV) morphine is most
frequently used [10]. Several studies have suggested that
prehospital pain relief for patients with suspected hip
fracture is inadequate, with up to 40% of patients not re-
ceiving any pain relief [11–16]. This shortfall may partly
be due to reluctance to administer opioids [17, 18].
Elderly people who sustain hip fractures often have
co-morbidities and are vulnerable to the side effects of
opioids [19, 20]. These side effects may need ameliorat-
ing by further treatments—for instance, naloxone for
respiratory depression, laxatives for constipation, or
dialysis for opioid accumulation in renal failure. Avoid-
ing opioids in this population may therefore reduce
morbidity and length of stay in hospital and improve
health-related quality of life [21–27].
Fascia iliaca compartment block (FICB) [28] is increas-
ingly used in emergency departments (EDs) and ortho-
paedic wards in the care of patients with hip fracture.
There is extensive evidence that FICB in-hospital is
straightforward to administer, can be performed by
non-medical health professionals, and provides adequate
pain relief with fewer side effects than opioids [29–47].
Prehospital FICB has been tested twice—in a prospective
observational study of 100 patients in the Netherlands
[48] and in a randomised trial of 35 patients in Australia
[49]. Both studies provided morphine to those receiving
FICB. Rapid Analgesia for Prehospital hip Disruption
(RAPID) is the first randomised trial of FICB before hos-
pital admission in which one arm avoids opioids.
We hypothesise that the use of FICB to provide pre-
hospital pain relief to patients with a hip fracture, thus
avoiding morphine, will improve patient outcomes. In
accordance with best practice in evaluating complex in-
terventions [50], we tested the feasibility of delivering
FICB and of associated trial methods.
Aim
To assess the feasibility of undertaking a fully powered,
multi-centre randomised controlled trial (RCT) to test
the clinical and cost-effectiveness of paramedics providing
FICB as early pain relief to patients with hip fracture.
Objectives
To assess:
1. Willingness of both patients and paramedics to
participate in the trial
2. Compliance with the FICB protocol by paramedics
3. Which outcome measures and costs to use in a full
RCT and when they should be collected
4. Acceptability of FICB to provide pain relief in the
prehospital care of patients with hip fracture
5. Accuracy of recognition of hip fracture by
paramedics
6. Sample size required for a fully-powered RCT, the
period and number of sites required to recruit these
7. Whether trial processes and outcomes achieve
specified progression criteria for progress to fully-
powered trial
Methods
Trial design
Single-centre randomised parallel-group feasibility trial,
with allocation ratio 1:1 and qualitative data collection [51].
Changes after the study began
1. The Principal Investigator (PI) in the receiving
hospital (SF) could provide assent for patients who
died before being approached for consent. In the
study population, there were likely to be deaths
before consent could be sought. As mortality was
an outcome of this trial, to exclude patients who
died before consent could be sought would mean
that the results were not valid for the population.
Obtaining consent from a consultee regarding the
use of routinely collected healthcare data for
research in these circumstances would be
distressing. We therefore obtained approval for the
local PI to sign an Early Mortality Declaration Form
to confirm that the patient has died, and take
responsibility for the use of routinely collected
healthcare data for this trial.
2. Patients could consent to follow-up of medical data
alone, but not to complete questionnaires. This was
changed following low consent rates in the first few
weeks of the study, and with input from the Paramedic
Research Support Officer (PRSO) and Patient and
Public Involvement (PPI) members, as we thought
some patients would prefer not to complete
questionnaires.
3. We included the Quality of Care Monitor in postal
questionnaires sent to participants after 1 month
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instead of when approaching them earlier for
consent. We changed this following feedback from
the PRSO and PPI members, who indicated that the
original approach of completing the questionnaire
with the PRSO present might make patients feel
uncomfortable.
4. To improve the response rate of self-reported
outcome measures, we sent reminders to non-
responding participants 2 and 4 weeks after their
initial questionnaire.
Setting
We conducted the trial in the catchment area of one
hospital emergency department in Wales.
Participants
Inclusion criteria:
Adult patients attended by a participating study para-
medic following a 999 call in the catchment area of the
receiving hospital and assessed as having an isolated hip
fracture, using a checklist developed for the study (Fig. 1);
conscious (Glasgow Coma Scale Score of ≥13); and
haemodynamically stable.
Exclusion criteria:
Patients who refused analgesia or were combative or
attended by a participating paramedic working alone.
Patient consent
As per normal practice, paramedics sought oral consent
to administer analgesia. As it is not ethically appropriate
to consent patients to research in medical emergencies
[52], the PRSO (LK) sought consent from the patient, or
assent from a relative or friend or the hospital PI, to take
part in the trial within approximately ten working days
of the injury [53–56].
Data collection
We collected routine data from ambulance service clinical
records and hospital notes for each consented participant.
We posted questionnaires to patients and enclosed
stamped addressed envelopes. We stored all data in
REDCap and assured the quality of these data [57].
Appropriate and well-conducted qualitative research
can make an important contribution to feasibility studies
for randomised controlled trials providing information
on acceptability and practical implementation issues [58,
59]. We aimed to interview ten participants who had re-
ceived FICB—by telephone or in their homes, according
to their preference—to explore their experience of re-
ceiving FICB and acceptability of the intervention.
Towards the end of the recruitment period, we
planned to conduct three focus groups with paramedics
in a local ambulance station. We invited all trial para-
medics to take part and offered them honoraria to reim-
burse their time. We sought experiences of receiving
training and administering FICB. With participants’ con-
sent, we audio-recorded interviews and focus groups
and transcribed these for analysis.
The aim of the health economics was to establish the
feasibility of an economic evaluation alongside the main
trial. The specific objectives of the health economic com-
ponent were to identify the relevant NHS and non-NHS
resource use to be collected alongside the main trial, to de-
termine acceptability and completeness of resource use
and utility measures, and to give preliminary estimates of
the NHS costs of the intervention. We estimated
intervention training costs using trainers’ hourly pay
rates, amortised material and equipment costs, and
estimated numbers of patients attended by trained
paramedics.
Interventions
The experimental intervention comprised two elements:
1. Paramedic training
We trained paramedics to perform FICB using an on-
line package, including a video showing the administra-
tion of FICB, a 3-h classroom session led by a consultant
anaesthetist (SF), and training sessions at the participat-
ing hospital to administer FICB to patients. We required
paramedics to successfully perform at least three blocks
and to critique three blocks before recruiting patients to
the study. We offered refresher training at any time dur-
ing the patient recruitment period.
2. FICB administration
Paramedics administered FICB after ensuring the pa-
tient did not have any of the contraindications in Fig. 2.
They could provide the patient with paracetamol and
Entonox in addition to FICB, but were asked not to give
morphine for at least 20 min after the patient had re-
ceived the FICB, and then only if the FICB had not
Fig. 1 Hip Fracture Assessment Checklist
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relieved the patient’s pain. The detailed protocol for ad-
ministering FICB, which complies with the TIDieR
checklist [60], is in Additional file 1: Table S1.
Usual care:
Patients randomly allocated to the control arm receive
usual pain relief care (Entonox, paracetamol and mor-
phine), as judged appropriate by the paramedic.
We collected the following proposed outcome mea-
sures for the fully powered trial:
Primary
Self-reported health-related quality of life, using SF-12
[35] at 1 and 6months; mortality within 6 months.
Secondary
Self-reported:
 Mobility, using the modified Rivermead Mobility
Index [36] at 1and 6 months
 Satisfaction with care using a modified Quality of
Care Monitor [38] at 1 month
 Qualitative data from patient interviews and
paramedic focus groups
Routinely collected:
 Length of inpatient stay
 Duration of paramedic management of patient (from
paramedic arrival to ED handover)
 Use of anti-emetics and analgesia
 Time between ED handover and surgery
 Pain scores, recorded prior to randomisation by
attending paramedic, and on arrival at ED by triage
nurse
 Serious adverse events (SAEs) within 7 days of 999 call
Due to time constraints, only those patients recruited
in the first 7 months of the trial who were alive were
followed up with a 6-month questionnaire.
To assess accuracy of paramedic recognition of hip
fracture, the PRSO followed up randomised participants
and identified other patients with hip fracture attended
by trial paramedics within the period of the trial from
hospital records.
Outcomes
To meet our feasibility objectives, we measured the
following outcomes:
1. a) Number of paramedics who volunteer to take
part in the trial
b) Percentage of randomised patients who consent
to follow-up in the trial
2. Percentage of patients randomly allocated to the
experimental group who receive FICB
3. a) Proportion of data we are able to collect for each
proposed primary outcome for a subsequent fully
powered trial
b) Assessment of whether any proposed outcome
measures for a subsequent fully powered trial
seemed to show significant differences between
groups
4. a) Satisfaction with care by the ambulance service,
measure using a Quality of Care Monitor
b) Safety
5. Sensitivity and positive predictive value of
paramedic recognition of hip fracture
6. Sample size, number of sites, and recruitment
period for fully powered, multicentre trial
7. Whether the trial meets its progression criteria
At the outset of the feasibility trial, the Trial Manage-
ment Group (TMG), including the PPI representatives,
specified progression criteria mapped to these outcomes,
to be met within reasonable limits. These progression
criteria were agreed upon by the Trial Steering Commit-
tee (TSC).
1. Recruit at least ten paramedics to conduct the trial
2. At least 60% of recruited participants consent to
follow-up
3. At least 50% of intervention participants receive FICB
4. Retrieve primary outcomes for at least 70% of
consented participants
5. Clinicians are in equipoise about the safety and
effectiveness of paramedic-administered FICB
6. Mean participant satisfaction in the experimental
arm at least 80% of that in the usual care arm
7. Balance of SAEs between arms
8. Paramedics recognise hip fracture with sensitivity of
75% and positive predictive value of 85%
Sample size
Formal sample size power calculations were not performed
as this was a feasibility study, focussing on estimating pa-
rameters for a subsequent fully powered multi-centre trial,
Fig. 2 Contraindications to FICB
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rather than on formal testing of hypotheses. Based on the
throughput of patients with hip fracture at the participating
hospital [53], we judged that recruiting approximately 50
patients to RAPID would be practical and enable us to
assess whether the trial met our progression criteria.
Randomisation
We produced sequentially numbered scratchcards with
concealed trial arm allocation before recruiting patients.
The trial statistician (GF) produced randomisation sched-
ules that were stratified so that each paramedic received
ten scratchcards with five allocations to each arm.
Blinding
The nature of the intervention prevented us from blind-
ing paramedics and participants to allocation. The sec-
ond pain score, on arrival at the ED, was obtained from
the patient by the triage nurse, who was blinded to the
patient’s allocation.
Analysis
We used descriptive statistics to assess whether we had
met our progression criteria. We (GF and JKJ) con-
ducted statistical analysis by treatment allocated using
Stata version 15.0. We calculated descriptive statistics
only on baseline characteristics, for example, mean age
and age range in each group, and number and percentage
of female participants in each group. T tests and cross tab-
ulations were performed on potential primary and second-
ary outcomes for the full trial in order to determine if we
remained in equipoise as to whether paramedic adminis-
tered FICB was clinically and cost-effective. We undertook
inductive thematic analysis of data from interviews and
focus groups. Two researchers (BAE, JKB), the PRSO
(LK), and a representative of patients and the public (SJ)
separately read and re-read transcripts to identify
categories of data. These were discussed collectively
[61, 62] and grouped to generate themes. We used
NVIVO software to store transcripts and code data.
BAE undertook coding, then collated and drafted
these findings, for further input and reflection by the
group to test and confirm findings [63–65].
Descriptive analyses were used for the health econom-
ics. Market and NHS costs were used to determine pre-
liminary estimates of the cost of training paramedics,
and two sensitivity analyses were used to check the im-
pact of varying trainers’ grade and amount of paramedic
training sessions [66].
Public and patient involvement
Public and patient representatives contributed to design-
ing, delivering, overseeing, and disseminating the study.
We recruited people with experience of hip fracture, as
patients or carers, to the TMG and TSC. We provided
briefing sessions before all TMG and TSC meetings. We
report on these activities in accordance with the GRIPP2
checklist [67].
Results
We report feasibility study findings in accordance with
relevant CONSORT and GRIPP 2-SF checklists [67, 68];
the CONSORT flowchart is seen in Fig. 3.
Recruitment, consent, and response rates
Nineteen paramedics volunteered and successfully trained
to participate, thus achieving Progression Criterion 1. The
first 13 trained paramedics recruited participants from 28
June 2016 till 30 June 2017. Six additional paramedics
continued recruiting until 31 July 2017 as their training
took longer than expected owing to shift patterns; some
did not achieve competency until June 2017. Thus, para-
medic participation in the trial ranged from 6 to 52 weeks
(median 32 weeks). Five of the 19 paramedics did not re-
cruit any patients.
Thirty-one (89%) of 35 experimental participants and
26 of 36 (72%) allocated to usual care consented to
follow-up. Thus the overall consent rate was 80%, meet-
ing Progression Criterion 2.
In the experimental arm, 17 of 31 (55%) participants re-
ceived FICB, meeting Progression Criterion 3. Use of anti-
coagulants was the most common reason for not using
the allocated treatment, reported for nine participants.
Forty-nine participants consented to full follow-up; 30
(61%) participants returned their 1-month questionnaire
and 12 of 17 (71%) returned their 6-month question-
naire. We ascertained whether all participants were alive
at 6 months. Thus, we met Progression Criterion 4 for
two of our proposed primary outcomes, but not for
health-related quality of life at 1 month.
Baseline characteristics
The trial population was elderly (mean age 81.9 years,
range 63–101) and mainly female (79%). Trial arms were
balanced in age, gender, time of attendance, and attend-
ing paramedic at baseline (Table 1).
Outcome analyses
Though it should be noted that this feasibility study was
not powered to detect statistically significant differences,
we found none between trial arms in unadjusted primary
outcomes (Table 2). However, morphine was adminis-
tered in the experimental arm at approximately half the
rate observed in usual care—a statistically significant
difference. As we found no other statistically significant
differences between arms, notably in satisfaction with
care received, we satisfied Progression Criteria 5 and 6.
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Fig. 3 Flow of participants through the trial
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Harms
Three experimental participants experienced SAEs com-
pared to the four in the usual care arm, thus meeting
Progression Criterion 7. Of experimental participants,
one experienced local anaesthetic toxicity (successfully
treated by the attending paramedic with Intralipid with-
out any indication of long term sequelae), one died
within 7 days (from community-acquired pneumonia),
and one had sepsis and bowel obstruction (from pallia-
tively treated metastatic cancer). In the usual care arm,
one participant had rhabdomyolysis requiring dialysis
and intensive care, two patients died within 7 days (from
heart failure or pulmonary oedema), and one required a
blood transfusion.
Ancillary analyses
Accuracy of recognition of hip fracture by paramedics
From hospital records, we identified 15 ‘false nega-
tives’, i.e. patients eligible for the study, but not recog-
nised as hip fractures by the attending paramedic.
Trial paramedics recruited 11 ‘false positives’—partici-
pants without radiological evidence of hip or femoral
fracture. The resulting sensitivity of 46/61 (75.4%)
and positive predictive value of 46/57 (80.7%) thus
did not meet Progression Criterion 8, but were within
reasonable limits (Table 3).
Protocol deviations
We identified 12 protocol deviations (Additional file 2:
Table S2). The most common were scratchcards used
out of order, once deliberately we suspect, in order to
try to reveal an intervention allocation. One experimen-
tal participant received morphine before FICB.
Health economics
Using year 2017 cost figures, we estimated the cost of an
FICB pack to be £19, within the usual range of costs of
pain relief. From our single site, we estimated the basic
cost of training per patient per year of paramedic activity
as £102 with a senior trainer providing initial training,
increasing to £170 when the same trainer provides fur-
ther training. The corresponding costs with a junior
trainer were estimated as £88 for initial training and
£152 with further training. Though the saving of nine
hospital days per participant was not statistically signifi-
cant, the national cost of non-elective inpatient stays for
hip fracture suggest considerable potential for such sav-
ings to offset training costs, even by senior trainers with
further training, allowing for reasonable geographical
variation in training costs.
Qualitative results
Eleven paramedics, two female and nine male, took part
in three focus groups—one group of five and two groups
of three. Three paramedics had been qualified for less
than 5 years, three for more than 10 years, and the
remaining five for between 5 and 10 years.
Thirteen participants who received FICB consented to
interview. When we approached them for interview, one
patient who had some cognitive impairment consented
to her daughter undertaking the interview instead, since
she was present when her mother received FICB. Two
patients were too sick to take part, and we could not
contact four individuals. In total, we interviewed six pa-
tients and one daughter. Interviews took place between
6 and 30 weeks after injury.
Four themes were identified from the focus groups
with paramedics: ability and acceptability, patient safety
and experience, training, and scope of the paramedic
practice [69]. Three themes were identified from patient
interviews: memories of receiving pain management and
care from ambulance teams, experience of paramedic
care, and ongoing hospital treatment and rehabilitation.
Paramedics reported that FICB was a suitable inter-
vention for them to deliver, within their capabilities and
in alignment with current practice.
The RAPID trial has just fitted naturally into our
everyday pattern… It’s just given us another route of
pain relief for patients that definitely need it. (Focus
Group 1 - Paramedic 2)
Table 1 Baseline characteristics
Experimental Usual care
N 31 26
Mean age in years, (range) 81.5, (63.6–101.4) 82.2, (68.3–91.8)
Female, n (%) 25 (80.6%) 20 (76.9%)
Time of paramedic attendance
06:00–17:59 n (%) 18 (58.1%) 15 (57.7%)
18:00–05:59 n (%) 13 (41.9%) 11 (42.3%)
Attending paramedic ID, n (%)
1 1 (3.2%) 0 (0%)
2 2 (6.5%) 2 (7.7%)
4 3 (9.7%) 1 (3.8%)
5 1 (3.2%) 1 (3.8%)
6 2 (6.5%) 2 (7.7%)
7 5 (16.1%) 4 (15.3%)
8 4 (12.9%) 3 (11.5%)
9 3 (9.7%) 2 (7.7%)
10 2 (6.5%) 4 (15.3%)
12 2 (6.5%) 3 (11.5%)
13 4 (12.9%) 3 (11.5%)
14 0 (0%) 1 (3.8%)
16 1 (3.2%) 0 (0%)
17 1 (3.2%) 0 (0%)
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They were uncertain whether the block effectively re-
duced patients’ pain, citing examples where it appeared to
have made a difference and other instances where it had
not. However, they said the drug was potentially better for
patients because it reduced the risk of complications from
morphine. They reported that it did not change their ap-
proach to caring for patients but may have increased the
time before patients received pain relief by up to 10min.
I think it’s a fantastic idea to have (FICB) prehospitally
because people die from breaking their hip… they are
pumped full of morphine [in hospital] and then they
catch a chest infection and they die. It’s something
that we can do prehospitally to relieve their pain but
Table 2 Outcomes by trial arm
Experimental Usual care Difference (95% CI)
Primary outcomes
Mortality/N 31 26
Died within 6 months, n (%) 4 (13%) 6 (23%) -10% (−31% to + 10%)
SF-12 @ 1month/N 14 9
Physical Health mean (SD) 30.1 (7.1) 36.3 (10.2) − 6.2 (− 13.6 to + 1.4)
Mental Health mean (SD) 40.6 (12.9) 34.4 (15.1) 6.2 (− 6.1 to + 18.4)
SF-12 @ 6months/N 4 2
Physical Health mean (SD) 34.2 (10.0) 42.6 (14.9) − 8.5 (− 36.0 to + 19.0)
Mental Health mean (SD) 44.3 (18.4) 57.8 (4.6) − 13.5 (− 52.2 to + 25.2)
Secondary Outcomes
Satisfaction with care/N 20 13
Mean (SD) 3.4 (0.4) 3.5 (0.5) − 0.1 (− 0.4 to + 0.2)
Modified Rivermead Mobility Index
One month, N 18 12
Mean (SD) 5.2 (3.2) 6.7 (3.3) − 1.4 (− 3.9 to + 1.0)
Six months, N 7 4
Mean (SD) 8.3 (3.2) 9.8 (2.5) − 1.5 (− 5.8 to + 2.8)
Pain score, N 23 14
Mean (SD) 3.7 (2.7) 4.1 (2.7) − 0.4 (− 2.3 to + 1.5)
Medication by paramed/N 31 26
Entonox % (n) 3% (1) 4% (1) − 0.6% (− 10% to + 9%)
Paracetamol % (n) 52% (16) 81% (21) − 29% (− 52% to + 5%)
Morphine % (n) 42% (13) 81% (21) − 39% (− 62% to − 16%)
Ondansetron % (n) 35% (11) 23% (6) + 12% (− 11% to + 36%)
Time with participant/N 31 26
Mean in minutes (SD) 79.8 (28.2) 74.8 (22.6) 5.0 (− 8.8 to + 18.7)
Time participant in ED/N 25 17
Mean in minutes (SD) 2069 (1694) 2044 (1319) 25 (− 962 to + 1012)
Length of hospital stay/N 29 21
Mean in days (SD) 17.7 (15.2) 26.8 (24.8) − 9.1 (− 20.5 to 2.3)
The satisfaction with care score is the mean of the final nine question scores; higher scores denote higher satisfaction. The Rivermead Mobility Index score sums
the question scores; higher scores denote better mobility
Table 3 Recognition of hip fracture by paramedics
Hip fracture or femoral
fracture on X-ray
No hip or femoral
fracture on X-ray
Total
Recruited 46 11 57
Not recruited 15
Total 61
Sensitivity (46/61) 75.4%
PPV (46/57) 80.7%
We designated three participants with shaft of femur fractures (which FICB would
have benefitted) as ‘true positives’ on the advice of the independent TSC. Of the
‘false positives’, three patients had suffered with other fractures—of acetabulum,
pelvis, or pubic ramus, but they would not have benefitted from FICB
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also for them to have a more successful outcome.
(Focus Group 3 – Paramedic 9)
Respondents praised the training and refresher ses-
sions they received, including the chance to practise with
specialists. Suggested ways to improve the training in-
cluded prehospital scenario-based training, frequent re-
fresher sessions with hospital patients, becoming more
familiar with the trial packs, and increasing awareness of
the intervention among non-trial staff. Challenges re-
ported included delivering the intervention when family
or the public were present, needing to move the patient to
administer the injection, being the only trial paramedic on
a vehicle, and fearing their skills had decayed when not
regularly used. Paramedics supported the use of scratch
cards to allocate patients randomly because it was quick
and simple and because the card fitted in their pocket.
Participants reported that they had fallen in the house
or garden, often when alone, and had waited up to 6 h
for an ambulance. Their memories of prehospital care
were dominated by their experience of extreme pain, al-
though they did recall the quality of care they received
and praised paramedics for their reassuring and calm
manner.
I cannot remember exactly what was happening
because I was in so much pain. I think somebody gave
me something to ease the pain…whatever they did for
me, it eased that terrific pain. (Patient 111)
They explained everything – the situation and the
reason, did I want to try this and all this. I was glad to
see them come in. It was perfect. I could not wish for
better. (Patient 78)
Just one respondent recalled the offer of FICB because
the paramedic suggested it would enable them to carry
him to the ambulance in a chair rather than by stretcher
through a window. Participants’ priorities were to reduce
the pain of the hip fracture and to regain their mobility
and independence. Those who were aware of receiving
the block, from what they were subsequently told, said
they were happy with the intervention.
Sample size required for a full trial
We calculate that 1900 analysable outcomes would suf-
fice to detect a 3-day difference (which we judge to be
clinically important) in mean length of inpatient stay
(currently 18.5 days) between arms with 90% power and
95% significance level. Our sample size considerations
are based around a standardised statistical effect of 0.15,
which requires 950 analysable outcomes per arm. Con-
sidering the rate of recruitment in this feasibility study
(0.1 patient randomised per patient per week), likely
dissent rate (10%), and rate of inability to match patients
in the Secure Anonymised Information Linkage (SAIL)
databank in Wales and NHS Digital in England (1%), we
believe study paramedics would need to randomly allo-
cate 2132 patients in total.
The standardised statistical effect is based on the
log-Normal distribution (to reflect known skewness in
raw LOS), using means and standard deviations which
correspond to a difference of 3 days in mean LOS (see
above), and reflect feasibility data on SD in LOS (approxi-
mately 20 days) in LOS. We supplemented our calcula-
tions with extensive simulation experiments to confirm a
standardised statistical effect of ~ 0.15 for both raw and
logarithmically transformed LOS.
We will assess heterogeneity in LOS between sites
through descriptive statistics; if indicated, we will include
an appropriate site (fixed or random) effect term in stat-
istical models and use residual diagnostics to determine
which yields the better fit.
We envisage that this target would need six collaborat-
ing centres each with an average of 40 trained para-
medics recruiting patients for 24 months—this takes into
account anticipated attrition in study paramedics (due,
for example, to sick leave, maternity leave, or career pro-
gression). Each site would therefore be expected to re-
cruit approximately 355 patients, though this would vary
based upon the different sized catchment areas and
population demographics of the receiving hospitals. The
recruitment target is thus less than 1% of an estimated
total of 237,600 patients estimated to be attended by
study paramedics during the recruitment period.
Public and patient involvement
One of the patient representatives on the TMG attended
meetings; the other, unable to travel, contributed through
emails and telephone. One patient representative attended
TSC meetings. The TMG adopted a patient representative
role description describing expectations and available
support. The TSC included similar information in its
charter.
These patient representatives contributed in several
ways in meetings and analysis, including:
 Highlighting consequences of hip fracture and
importance of treatment and care
 Advising on obtaining pain scores from injured
patients
 Editing patient information sheets to simplify text,
reduce content, and add images and space
 Speaking at dissemination events about the impact
of hip fracture on vulnerable patients
 Contributing to trial publications as named authors,
in particular lay sections.
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Discussion
The RAPID feasibility study met its objectives and
achieved all of its progression criteria within reasonable
limits (summarised in Table 4). Our findings add to the
evidence base that paramedics can administer FICB in
prehospital care; whether they should do so remains to
be determined.
Limitations
Of experimental participants, 89% consented to follow-up,
compared with 72% of those allocated to usual care;
though this difference of 17% is not statistically significant,
the full trial will need to guard against, or adjust for, ‘resent-
ful demoralisation’ among control participants.. Though
we blinded assessors to the treatments allocated, we could
not blind paramedics or patients to the treatment they re-
ceived, and sham FICB would be unethical.
Paramedics used randomisation scratchcards out of
order on four occasions. Although this did not unbal-
ance arms, we shall in future provide scratchcards in a
booklet with different fronts and backs so that the cards
must be taken in order.
As we stratified randomisation by paramedic, the one
who recruited nine participants could have predicted the
tenth scratchcard. In future, we shall avoid this risk by
using variable block sizes.
This feasibility trial invited paramedics to volunteer; in a
full trial, we would need a greater number of paramedics
in each site (approximately 40) which may be a challenge.
However, other large prehospital trials have recruited
significant numbers of paramedics (PARAMEDIC was
conducted in four ambulance services and 418 emergency
vehicles were recruited—either double-staffed ambulances
or single-staffed rapid response vehicles [55]; AIRWAYS-2
was also conducted in four ambulance services and 1523
paramedics were trained [70]). We would monitor re-
cruitment rates closely in the first few months of the
trial to ensure the study paramedics are engaged with
the trial and make any necessary modifications to im-
prove recruitment rates.
We do not know why some paramedics did not recruit
any patients: some may have been those not fully trained
until late into the recruitment period; they may have had
sick or annual leave; or been working on cars (alone) and
therefore ineligible to recruit patients. We plan to monitor
for paramedics who do not recruit patients for 3months
or more in the full trial, so that they can be offered re-
fresher training to ensure they still feel confident enough
to recruit and randomly allocate patients to trial arms.
Table 4 Summary of findings by objective and Progression Criterion
Objectives [To assess:] Relevant Progression Criteria Relevant result
1. Willingness of both patients and
paramedics to participate in the trial.
1. Recruit at least ten paramedics to
conduct the trial
19 paramedics took part in the trial
2. At least 60% of recruited participants
consent to follow up
80% of patients consented to follow up
2. Compliance with the FICB protocol
by paramedics.
3. At least 50% of intervention
participants receive FICB
55% of intervention participants received FICB
3. Which outcome measures and costs
to use in a full RCT and when they
should be collected
4. Retrieve primary outcomes for at
least 70% of consented participants
We checked the mortality status for 100% of
participants. 61% of 1 month questionnaires
and 71% of 6 month questionnaires were
returned5. Clinicians are in equipoise about
safety and effectiveness of paramedic-
administered FICB The only statistically significant difference
between arms was the proportion receiving
morphine
4. Acceptability of FICB as a method of
providing pain relief in the prehospital
care of patients with hip fracture.
6. Mean participant satisfaction in the
experimental arm at least 80% of that
in the usual care arm
Mean participant satisfaction in FICB was 97%
of that in the usual care arm
7. Balance of SAEs between arms SAEs occurred in three experimental
participants and four in the usual care arm
5. Accuracy of recognition of hip fracture
by paramedics.
8. Paramedics recognise hip fracture
with sensitivity of 75% and positive
predictive value of 85%
Paramedics recognised hip fracture with
sensitivity 77% and positive predictive value
of 81%
6. Sample size required for a fully-powered
RCT and period required to recruit these
For example, ~ 1900 patients over 24 months.
7. Whether trial processes and outcomes
achieve specified progression criteria for
progress to fully-powered trial
We effectively met all progression criteria,
with progression criterion four being met for
two out of three proposed primary outcomes
and progression criterion eight being within
reasonable limits.
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Patient and public involvement
Most patients who suffer hip fractures are elderly and
frail and may have dementia. Hence, recruiting patient
representatives with relevant experience was challenging
[71]. Although we welcomed email and telephone con-
tributions from one TMG member who could not travel
to meetings, this left the other representative alone at
meetings. This reinforces agreed best practice which rec-
ommends a minimum of two representatives at meetings
and flexibility in accessing their contributions [72, 73].
In a full multi-centre trial, we will seek public and pa-
tient involvement at strategic, site, and local level to re-
duce the problems for individuals travelling to meetings
and to increase the number and roles of representatives.
We will also ensure adequate support plus a named con-
tact individual for public and patient members involved
in future research [74].
Interpretation and conclusion
We compared outcomes between trial arms only to con-
firm that we remain in equipoise about the clinical ef-
fectiveness of pre-hospital FICB for hip fracture
administered by paramedics (i.e. that there were no stark
differences between groups noted in a study not pow-
ered to detect this). Hence, we treat observed differences
in outcomes with caution in this feasibility trial.
The addition of the health economic perspective along-
side this feasibility will improve the efficiency of the main
trial. In line with the FORGE trial taskforce guidelines
[75], data collection forms were designed and tested in
order to capture the NHS resource usage relevant in
addressing the research questions, e.g. the time para-
medics spent with patients. Missing data is a big issue for
health economic evaluation alongside multicentre trials;
we would therefore propose to collect resource data from
routinely collected databased in the multi-centre trial (i.e.
SAIL and NHS Digital).
As responses to questionnaires only just met our pro-
gression criterion at the 6-month time point and did
not meet our criterion at the 1-month time point,
health-related quality of life may not be the best pri-
mary outcome in a full trial without modification. For
example, we would need to increase the emphasis on
telephone follow-up, as our 6-month questionnaire re-
turn rate was boosted by this means in the feasibility
study, and we would use incentives, which have been
proven to improve response rates [76, 77]. Further-
more, the sample size required to detect a plausible dif-
ference in mortality would be infeasibly high. Length of
inpatient stay is available for all patients and showed a
clinically relevant, though statistically insignificant, dif-
ference between arms within the feasibility study. We
shall therefore consider this as the primary clinical out-
come of the definitive trial.
This feasibility study generally met its pre-determined
progression criteria within reasonable limits; an applica-
tion has therefore been prepared and submitted for
funding for a fully powered multi-centre randomised
trial of paramedic-administered FICB. This application
will take into account factors that we have learnt from
this feasibility study, for example, allocating enough time
for training, providing refresher training, and making
non-trial staff aware of the trial. As the positive predict-
ive value of paramedic recruitment of hip fracture failed
to reach our pre-specified progression criterion, we
propose to monitor for false-positive recruitments dur-
ing the fully powered trial so that we can ensure any
paramedics that need further training in the recognition
of hip fracture are identified as early as possible.
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